Dr Michael J Strong
Western University, Canada
"Are we there yet? Measuring nonmotor progression in amyotrophic lateral sclerosis"
Dr. Strong's clinical research has focused on defining the clinical and neuropathological characteristics of the frontotemporal spectrum disorder of ALS. His lab has provided key insights into the role of altered tau metabolism in FTSD-ALS, and in providing novel insights into the role of altered mRNA biogenesis in ALS.
Dr. Strong has published over 200 peer-reviewed articles, edited four textbooks, and given over 170 lectures on ALS research. He is a recipient of both the Sheila Essey Award and the Forbes Norris Award, and in 2012 he was awarded the Queen Elizabeth II Diamond Jubilee Medal for his contributions to ALS research and care.